Skin lesions may hold the key to diagnosing dengue, Zika, chikungunya, and Oropouche fever. Learn how dermatologists can spot ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

Valneva's chikungunya vaccine Ixchiq receives Brazil approval, enabling expanded trials and access across Latin America and ...

Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency (ANVISA) for its single-dose ...

Health authorities have raised concerns over a noticeable increase in the spread of the Chikungunya virus, which is ...

Dengue and chikungunya are spread by the Aedes aegypti mosquito. Symptoms appear within 7 days of being bitten by a mosquito.

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

About Chikungunya Chikungunya virus (CHIKV) is a mosquito-borne viral ... nausea, fatigue and rash. Joint pain is often debilitating and can persist for weeks to years 10. We are a specialty ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose ...

About Chikungunya Chikungunya virus (CHIKV) is a mosquito-borne viral disease spread by the bites of infected Aedes mosquitoes which causes fever, severe joint and muscle pain, headache, nausea, ...